A $42 million verdict on Tuesday in Boston is the newest for a plaintiff alleging Johnson & Johnson’s child powder prompted mesothelioma.
Trending
- Brussels to give carmakers breathing space on 2030 climate targets
- Canada clears way for $60bn Anglo Teck merger
- UK and South Korea strike trade deal
- Runway announces its AI general world model GWM-1
- UK unemployment rate rises slightly to 5.1%
- Juventus bid battle brings a new meaning to ‘crypto vs fiat’
- Thousands of drivers wrongly fined for speeding since 2021
- Landmark agreement means Disney characters are coming to OpenAI Sora
Johnson & Johnson Hit With $42M Talc Verdict in Boston
